Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017555

Chief Medical Officer gave up 7,940 shares (to pay taxes)

  • Chief Medical Officer acquired 28,897 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gordon David N. Chief Medical Officer 2021-03-01 Option exercise +20,600 108,135 D
Gordon David N. Chief Medical Officer 2021-03-01 Shares withheld for taxes −5,660 $24.06 $136,180 102,475 D
Gordon David N. Chief Medical Officer 2021-03-02 Option exercise +8,297 110,772 D
Gordon David N. Chief Medical Officer 2021-03-02 Shares withheld for taxes −2,280 $23.25 $53,010 108,492 D
Derivatives
Gordon David N. Chief Medical Officer 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +99,500 99,500 D
Gordon David N. Chief Medical Officer 2021-03-01 Grant or award · Restricted stock units +28,400 28,400 D
Gordon David N. Chief Medical Officer 2021-03-01 Option exercise · Restricted stock units −20,600 41,200 D
Gordon David N. Chief Medical Officer 2021-03-02 Option exercise · Restricted stock units −8,297 24,892 D
Loading xslF345X03/doc4.xml…